Forward Lymphoma Research Team
Under the leadership of program director, Dr. Brad Kahl, lymphoma research at the University of Wisconsin Comprehensive Cancer Center takes an interdisciplinary, transitional approach to research. Translational research seeks to bridge the gap that can occur in basic scientific research done in controlled laboratory and clinical research settings. Studies are completed on human tissue from the organ bank to maximize the application of research to humans instead of tests on laboratory animals.
The research team consists of University of Wisconsin faculty members dedicated to lymphoma research. These elite researchers consist of the following:
- Brad S. Kahl, MD
- Catherine Leith, MB, Bchir
- David Yang, PhD
- Erik A. Ranheim, MD, PhD
- Peiman Hematti, MD
- Shigeki Miyamoto, PhD
Learn More about the Research Team If you are interested in learning more about the research team, email Dr. Brad Kahl at bsk@medicine.wisc.edu.
Get More from Forward Lymphoma
Sign up to receive more information from Forward Lymphoma and the Carbone Cancer Center.
Download the Helping Lymphoma Patients with Research Focused on Psychological Recovery white paper.
Download the Determining Who is Right for Rituximab white paper.
Download the Using Stem Cells to Develop Patient Specific Treatments white paper.
